See the DrugPatentWatch profile for icatibant
What is icatibant, and who makes it?
Icatibant is a medicine used to treat attacks of hereditary angioedema (HAE) by blocking the bradykinin B2 receptor (it counteracts the bradykinin pathway involved in HAE attacks). Fresenius Kabi is a company that sells pharmaceuticals, and the product name you may be searching for is likely an icatibant brand distributed by Fresenius Kabi in some countries.
Is there an icatibant product specifically from Fresenius Kabi?
Fresenius Kabi can market and distribute medicines under different brand names depending on the country. To confirm the exact “Fresenius Kabi icatibant” product you mean (brand name, strength, and formulation), you usually need the country or the specific packaging label.
What is icatibant used for (especially in hereditary angioedema)?
Icatibant is indicated for the acute treatment of HAE attacks in patients who have hereditary angioedema. It is designed to stop an ongoing attack by reducing bradykinin-mediated swelling.
How is icatibant typically taken during an attack?
Icatibant is given as an injection for an HAE attack. In many markets, patients or caregivers may be trained to self-administer according to local instructions and prescribing information.
What side effects are patients asking about?
Commonly reported issues with icatibant include injection-site reactions (such as redness, swelling, pain, or itching). Other side effects can occur, so the exact risk profile depends on the specific product and local prescribing information.
Which details should you check on the Fresenius Kabi packaging?
If you’re trying to identify the exact product, check:
- Brand name and strength on the box
- Dosage form (for example, prefilled syringe)
- Country-specific instructions and prescribing leaflet
If you tell me your country (or the brand name shown on the box), I can help pin down the exact Fresenius Kabi icatibant product and its use instructions more precisely.